Biomarkers in acute myocardial injury

Translational Research

Volumn 159, Issue 4, 2012, Pages 252-264

  Kehl, Devin W ^a,b   Iqbal, Navaid ^a,b   Fard, Arrash ^a,b   Kipper, Ben A ^a,b   De La Parra Landa, Alejandro ^a,b   Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; CHOLINE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; MYELOPEROXIDASE; MYOGLOBIN; PLACENTAL GROWTH FACTOR; TROPONIN C; TROPONIN I; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; BIOASSAY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL TRIAL (TOPIC); DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; FALSE POSITIVE RESULT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; ISCHEMIA; KIDNEY FAILURE; LEUKOCYTE COUNT; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SUBUNIT; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

EID: 84858383897     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.11.002     Document Type: Review

References (128)

1. T.H. Lee, G.W. Rouan, and M.C. Weisberg Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room Am J Cardiol 60 1987 219 224
2. J.H. Pope, T.P. Aufderheide, and R. Ruthazer Missed diagnoses of acute cardiac ischemia in the emergency department N Engl J Med 342 2000 1163 1170
3. K. Thygesen, J.S. Alpert, and H.D. White Infarction JEAAWTFftRoM. Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
4. F.S. Apple, R.L. Jesse, and L.K. Newby National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes Circulation 115 2007 e352 e355
5. R. Roberts, and B.E. Sobel Ediortial: isoenzymes of creatine phosphokinase and diagnosis of myocardial infarction Ann Intern Med 79 1973 741 743
6. M.A. Daubert, and A. Jeremias The utility of troponin measurement to detect myocardial infarction: review of the current findings Vasc Health Risk Manag 6 2010 691 699
7. D.A. Morrow, C.P. Cannon, and R.L. Jesse National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes Clin Chem 53 2007 552 574
8. W. Gerhardt, G. Nordin, and L. Ljungdahl Can troponin T replace CK MBmass as "gold standard" for acute myocardial infarction ("AMI")? Scand J Clin Lab Invest Suppl 230 1999 83 89
9. J.P. Higgins, and J.A. Higgins Elevation of cardiac troponin I indicates more than myocardial ischemia Clin Invest Med 26 2003 133 147
10. H.A. Katus, A. Remppis, T. Scheffold, K.W. Diederich, and W. Kuebler Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction Am J Cardiol 67 1991 1360 1367
11. B.J. Freda, W.H. Tang, F. Van Lente, W.F. Peacock, and G.S. Francis Cardiac troponins in renal insufficiency: review and clinical implications J Am Coll Cardiol 40 2002 2065 2071
12. J.H. Diris, C.M. Hackeng, and J.P. Kooman Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients Circulation 109 2004 23 25
13. J.F. Tucker, R.A. Collins, and A.J. Anderson Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction Acad Emerg Med 4 1997 13 21
14. E.M. Balk, J.P. Ioannidis, D. Salem, P.W. Chew, and J. Lau Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis Ann Emerg Med 37 2001 478 494
15. A.K. Saenger, and A.S. Jaffe The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes Med Clin North Am 91 2007 657 681
16. A.H. Wu, X.M. Wang, T.G. Gornet, and J. Ordóñez-Llanos Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction Clin Chem 38 1992 2396 2400
17. P.R. Puleo, P.A. Guadagno, and R. Roberts Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB Circulation 82 1990 759 764
18. J.C. Lin, F.S. Apple, M.M. Murakami, and R.V. Luepker Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes Clin Chem 50 2004 333 338
19. J. Zimmerman, R. Fromm, and D. Meyer Diagnostic marker cooperative study for the diagnosis of myocardial infarction Circulation 99 1999 1671 1677
20. T. Jernberg, B. Lindahl, S. James, G. Ronquist, and L. Wallentin Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram Am J Cardiol 86 2000 1367 1371
21. M.H. Ellestad, R. Startt-Selvester, and E. Stanton The utility of four biochemical markers in the triage of chest pain patients Cardiology 93 2000 242 248
22. A.K. Saenger A tale of two biomarkers: the use of troponin and CK-MB in contemporary practice Clin Lab Sci 23 2010 134 140
23. C.A. Polanczyk, P.A. Johnson, E.F. Cook, and T.H. Lee A proposed strategy for utilization of creatine kinase-MB and troponin I in the evaluation of acute chest pain Am J Cardiol 83 1999 1175 1179
24. J. Mair, E. Artner-Dworzak, and P. Lechleitner Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin Br Heart J 68 1992 462 468
25. S.F. Melanson, E.L. Lewandrowski, J.L. Januzzi, and K.B. Lewandrowski Reevaluation of myoglobin for acute chest pain evaluation: would false-positive results on "first-draw" specimens lead to increased hospital admissions? Am J Clin Pathol 121 2004 804 808
26. R.J. de Winter, R.W. Koster, A. Sturk, and G.T. Sanders Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room Circulation 92 1995 3401 3407
27. G. Gilkeson, M.J. Stone, and M. Waterman Detection of myoglobin by radioimmmunoassay in human sera: its usefulness and limitations as an emergency room screening test for acute myocardial infarction Am Heart J 95 1978 70 77
28. J. McCord, R.M. Nowak, and M.P. Hudson The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome Ann Emerg Med 42 2003 343 350
29. M. Weber, O. Bazzino, and J.L. Navarro Estrada Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome Am Heart J 162 2011 81 88
30. M. Panteghini, F. Pagani, and K.T. Yeo Evaluation of imprecision for cardiac troponin assays at low-range concentrations Clin Chem 50 2004 327 332
31. A.S. Jaffe, B. Lindahl, and H.A. Katus Sensitive troponin I assay in patients with suspected acute coronary syndrome JAMA 306 2011 488 489
32. K. Thygesen, J. Mair, and H. Katus Recommendations for the use of cardiac troponin measurement in acute cardiac care Eur Heart J 31 2010 2197 2204
33. T. Reichlin, W. Hochholzer, and S. Bassetti Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 2009 858 867
34. T. Keller, T. Zeller, and D. Peetz Sensitive troponin I assay in early diagnosis of acute myocardial infarction N Engl J Med 361 2009 868 877
35. E. Giannitsis, K. Kurz, and K. Hallermayer Analytical validation of a high-sensitivity cardiac troponin T assay Clin Chem 56 2010 254 261
36. E. Giannitsis, M. Becker, and K. Kurz High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission Clin Chem 56 2010 642 650
37. F.S. Apple, L.A. Pearce, S.W. Smith, J.M. Kaczmarek, and M.M. Murakami Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events Clin Chem 55 2009 930 937
38. H.D. White Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 57 2011 2406 2408
39. J.L. McDonough, D.K. Arrell, and J.E. Van Eyk Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury Circ Res 84 1999 9 20
40. M.H. Hessel, D.E. Atsma, and E.J. van der Valk Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation Pflugers Arch 455 2008 979 986
41. P.E. Hickman, J.M. Potter, and C. Aroney Cardiac troponin may be released by ischemia alone, without necrosis Clin Chim Acta 411 2010 318 323
42. S. Homma, and C. Grahame-Clarke Editorial comment-myocardial damage in patients with subarachnoid hemorrhage Stroke 35 2004 552 553
43. S.D. Katz, K. Hryniewicz, and I. Hriljac Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure Circulation 111 2005 310 314
44. A. Mingels, L. Jacobs, and E. Michielsen Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays Clin Chem 55 2009 101 108
45. N. Mousavi, A. Czarnecki, and K. Kumar Relation of biomarkers and cardiac magnetic resonance imaging after marathon running Am J Cardiol 103 2009 1467 1472
46. E.D. Missov, and T. De Marco Clinical insights on the use of highly sensitive cardiac troponin assays Clin Chim Acta 284 1999 175 185
47. J.A. de Lemos, M.H. Drazner, and T. Omland Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population JAMA 304 2010 2503 2512
48. T.W. Wallace, S.M. Abdullah, and M.H. Drazner Prevalence and determinants of troponin T elevation in the general population Circulation 113 2006 1958 1965
49. L.B. Daniels, G.A. Laughlin, P. Clopton, A.S. Maisel, and E. Barrett-Connor Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study J Am Coll Cardiol 52 2008 450 459
50. C. Chenevier-Gobeaux, C. Meune, and M.C. Blanc Analytical evaluation of a high-sensitivity troponin T assay and its clinical assessment in acute coronary syndrome Ann Clin Biochem 48 2011 452 458
51. N. Shayanfar, L. Bestmann, G. Schulthess, and M. Hersberger False-positive cardiac troponin T due to assay interference with heterophilic antibodies Swiss Med Wkly 138 2008 470
52. A.H. Wu, Q.A. Lu, J. Todd, J. Moecks, and F. Wians Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice Clin Chem 55 2009 52 58
53. A.T. Turer, T.A. Addo, and J.L. Martin Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study J Am Coll Cardiol 57 2011 2398 2405
54. K. Kurz, E. Giannitsis, J. Zehelein, and H.A. Katus Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia Clin Chem 54 2008 1234 1238
55. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, P. Jarolim, and E. Braunwald Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 Eur Heart J 30 2009 162 169
56. S.R. Wilson, M.S. Sabatine, and E. Braunwald Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial Am Heart J 158 2009 386 391
57. D.M. Needham, K.A. Shufelt, G. Tomlinson, J.W. Scholey, and G.E. Newton Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature Can J Cardiol 20 2004 1212 1218
58. E.M. Antman, M.J. Tanasijevic, and B. Thompson Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes N Engl J Med 335 1996 1342 1349
59. E.M. Ohman, P.W. Armstrong, and R.H. Christenson Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators N Engl J Med 335 1996 1333 1341
60. H. Dokainish, M. Pillai, and S.A. Murphy Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy J Am Coll Cardiol 45 2005 19 24
61. A.K. Hassan, S.C. Bergheanu, and H. Hasan-Ali Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention Am J Cardiol 103 2009 779 784
62. K. Kurz, C. Schild, P. Isfort, H.A. Katus, and E. Giannitsis Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction Clin Res Cardiol 98 2009 94 100
63. D.A. Morrow, C.P. Cannon, and N. Rifai Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA 286 2001 2405 2412
64. N.L. Mills, A.M. Churchhouse, and K.K. Lee Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome JAMA 305 2011 1210 1216
65. W.A. Gattis, C.M. O'Connor, and V. Hasselblad Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial) Am J Cardiol 93 2004 1436 1437
66. R. Latini, S. Masson, and I.S. Anand Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 2007 1242 1249
67. T. Omland, J.A. de Lemos, and M.S. Sabatine A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med 361 2009 2538 2547
68. T. Otsuka, T. Kawada, C. Ibuki, and Y. Seino Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease Am Heart J 159 2010 972 978
69. H. Yasue, M. Yoshimura, and H. Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
70. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
71. A.M. Richards, M.G. Nicholls, and E.A. Espiner B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
72. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
73. J.L. Januzzi, C.A. Camargo, and S. Anwaruddin The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
74. K.M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome J Am Coll Cardiol 54 2009 357 364
75. S.Q. Khan, O.S. Dhillon, and R.J. O'Brien C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study Circulation 115 2007 2103 2110
76. T. Reichlin, W. Hochholzer, and C. Stelzig Incremental value of copeptin for rapid rule out of acute myocardial infarction J Am Coll Cardiol 54 2009 60 68
77. R. Sharma, D.C. Gaze, and D. Pellerin Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease Clin Sci (Lond) 113 2007 25 32
78. P. Musso, I. Cox, E. Vidano, D. Zambon, and M. Panteghini Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance Clin Biochem 32 1999 125 130
79. M.K. Sinha, D.C. Gaze, J.R. Tippins, P.O. Collinson, and J.C. Kaski Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention Circulation 107 2003 2403 2405
80. Y.W. Lee, H.J. Kim, and Y.H. Cho Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome Clin Chim Acta 384 2007 24 27
81. F. Peacock, D.L. Morris, and S. Anwaruddin Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department Am Heart J 152 2006 253 262
82. R.M. Lin, D.M. Fatovich, J.M. Grasko, and S.D. Vasikaran Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome Emerg Med J 27 2010 668 671
83. J. Quiles, D. Roy, and D. Gaze Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia Am J Cardiol 92 2003 322 324
84. M.K. Sinha, J.M. Vazquez, and R. Calvino Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction Heart 92 2006 1852 1853
85. D. Chan, and L.L. Ng Biomarkers in acute myocardial infarction BMC Med 8 2010 34
86. K. Viswanathan, N. Kilcullen, and C. Morrell Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative J Am Coll Cardiol 55 2010 2590 2598
87. C.G. McMahon, J.V. Lamont, and E. Curtin Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction Am J Emerg Med 2011 Jan 3 [Epub ahead of print]
88. K. Inoue, S. Suwa, and H. Ohta Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain Circ J 2011 Sep 21 [Epub ahead of print]
89. M. O'Donoghue, J.A. de Lemos, and D.A. Morrow Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes Circulation 114 2006 550 557
90. N. Kilcullen, K. Viswanathan, and R. Das Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values J Am Coll Cardiol 50 2007 2061 2067
91. D.P. Bathia, D.R. Carless, K. Viswanathan, A.S. Hall, and J.H. Barth Serum 99th centile values for two heart-type fatty acid binding protein assays Ann Clin Biochem 46 2009 464 467
92. K.M. Mullane, R. Kraemer, and B. Smith Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium J Pharmacol Methods 14 1985 157 167
93. K. Kalantar-Zadeh, M.L. Brennan, and S.L. Hazen Serum myeloperoxidase and mortality in maintenance hemodialysis patients Am J Kidney Dis 48 2006 59 68
94. B. Shao, M.N. Oda, J.F. Oram, and J.W. Heinecke Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein Curr Opin Cardiol 21 2006 322 328
95. M.C. Meuwese, E.S. Stroes, and S.L. Hazen Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 50 2007 159 165
96. M.L. Brennan, M.S. Penn, and F. Van Lente Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604
97. E. Cavusoglu, C. Ruwende, and C. Eng Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome Am J Cardiol 99 2007 1364 1368
98. K. Pietilä, A. Harmoinen, and W. Hermens Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy Eur Heart J 14 1993 915 919
99. I. Kushner, L. Rakita, and M.H. Kaplan Studies of acute-phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits J Clin Invest 42 1963 286 292
100. D.B. Diercks, J.D. Kirk, S. Naser, S. Turnipseed, and E.A. Amsterdam Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients Int J Emerg Med 4 2011 37
101. S. Ueda, U. Ikeda, and K. Yamamoto C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction Am Heart J 131 1996 857 860
102. B. Lindahl, H. Toss, A. Siegbahn, P. Venge, and L. Wallentin Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N Engl J Med 343 2000 1139 1147
103. R.J. de Winter, R. Bholasingh, and J.G. Lijmer Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction Cardiovasc Res 42 1999 240 245
104. C. Heeschen, C.W. Hamm, J. Bruemmer, and M.L. Simoons Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 antiplatelet therapy in unstable angina refractory to standard treatment trial J Am Coll Cardiol 35 2000 1535 1542
105. V. Bodí, J. Sanchis, and M.P. López-Lereu Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning J Am Coll Cardiol 46 2005 1747 1752
106. L.C. Correia, and J.P. Esteves C-Reactive protein and outcomes in acute coronary syndromes: a systematic review and meta-analysis Arq Bras Cardiol 97 2011 76 85
107. K.O. Pietilä, A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment Eur Heart J 17 1996 1345 1349
108. M.A. Pfeffer, E. Braunwald, and L.A. Moyé Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
109. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
110. L. Ceremuzynski, E. Kleczar, and M. Krzeminska-Pakula Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study J Am Coll Cardiol 20 1992 1056 1062
111. S.H. Zeisel, and K.A. da Costa Choline: an essential nutrient for public health Nutr Rev 67 2009 615 623
112. O. Danne, M. Möckel, and C. Lueders Prognostic implications of elevated whole blood choline levels in acute coronary syndromes Am J Cardiol 91 2003 1060 1067
113. F.S. Apple, A.H. Wu, and J. Mair Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin Chem 51 2005 810 824
114. C. Heeschen, S. Dimmeler, and S. Fichtlscherer Prognostic value of placental growth factor in patients with acute chest pain JAMA 291 2004 435 441
115. R. Glaser, W.F. Peacock, and A.H. Wu Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study Am J Cardiol 107 2011 821 826
116. V. Henn, S. Steinbach, K. Büchner, P. Presek, and R.A. Kroczek The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40 Blood 98 2001 1047 1054
117. D.A. Morrow, M.S. Sabatine, and M.L. Brennan Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J 29 2008 1096 1102
118. N. Varo, J.A. de Lemos, and P. Libby Soluble CD40L: risk prediction after acute coronary syndromes Circulation 108 2003 1049 1052
119. C. Heeschen, S. Dimmeler, and C.W. Hamm Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 2003 1104 1111
120. M. Weber, B. Rabenau, and M. Stanisch Influence of sample type and storage conditions on soluble CD40 ligand assessment Clin Chem 52 2006 888 891
121. F.S. Apple, L.A. Pearce, A. Chung, R. Ler, and M.M. Murakami Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome Clin Chem 53 2007 874 881
122. D. Schlittenhardt, A. Schober, and J. Strelau Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions Cell Tissue Res 318 2004 325 333
123. T. Kempf, M. Eden, and J. Strelau The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ Res 98 2006 351 360
124. J. Xu, T.R. Kimball, and J.N. Lorenz GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 2006 342 350
125. T. Kempf, J.M. Sinning, and A. Quint Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study Circ Cardiovasc Genet 2 2009 286 292
126. T. Kempf, E. Björklund, and S. Olofsson Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction Eur Heart J 28 2007 2858 2865
127. K.C. Wollert, T. Kempf, and B. Lagerqvist Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome Circulation 116 2007 1540 1548
128. A. Tello-Montoliu, F. Marín, and V. Roldán A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels J Intern Med 262 2007 651 658